The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Effects of Epoetin Alfa on Hematologic Parameters and Quality of Life in Cancer Patients Receiving Nonplatinum Chemotherapy: Results of a Randomized, Double-Blind, Placebo-Controlled Trial
Abstract
PURPOSE: This randomized, double-blind, placebo-controlled clinical trial assessed the effects of epoetin alfa on transfusion requirements, hematopoietic parameters, quality of life (QOL), and safety in anemic cancer patients receiving nonplatinum chemotherapy. The study also explored a possible relationship between increased hemoglobin and survival. PATIENTS AND METHODS: Three hundred seventy-five patients with solid or nonmyeloid hematologic malignancies and hemoglobin levels ≤ 10.5 g/dL, or greater than 10.5 g/dL but ≤ 12.0 g/dL after a hemoglobin decrease of ≥ 1.5 g/dL per cycle since starting chemotherapy, were randomized 2:1 to epoetin alfa 150 to 300 IU/kg (n = 251) or placebo (n = 124) three times per week subcutaneously for 12 to 24 weeks. The primary end point was proportion of patients transfused; secondary end points were change in hemoglobin and QOL. The protocol was amended before unblinding to prospectively collect and assess survival data 12 months after the last patient completed the study. RESULTS: Epoetin alfa, compared with placebo, significantly decreased transfusion requirements (P = .0057) and increased hemoglobin (P < .001). Improvement of all primary cancer- and anemia-specific QOL domains, including energy level, ability to do daily activities, and fatigue, was significantly (P < .01) greater for epoetin alfa versus placebo patients. Although the study was not powered for survival as an end point, Kaplan-Meier estimates showed a trend in overall survival favoring epoetin alfa (P = .13, log-rank test), and Cox regression analysis showed an estimated hazards ratio of 1.309 (P = .052) favoring epoetin alfa. Adverse events were comparable between groups. CONCLUSION: Epoetin alfa safely and effectively ameliorates anemia and significantly improves QOL in cancer patients receiving nonplatinum chemotherapy. Encouraging results regarding increased survival warrant another trial designed to confirm these findings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A sharper Bonferroni procedure for multiple tests of significance
HOCHBERG, Y. (1988) · Biometrika · doi:10.1093/biomet/75.4.800 · Cited by 4,829
Demetri, G. D., Kris, M., Wade, J., Degos, L., & Cella, D. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.10.3412 · Cited by 751
Albain, K. S., Crowley, J. J., LeBlanc, M., & Livingston, R. B. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.9.1618 · Cited by 728
Glaspy, J., Bukowski, R., Steinberg, D., Taylor, C., Tchekmedyian, S., & Vadhan-Raj, S. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.3.1218 · Cited by 693
Cella, D. F. (1997) · PubMed · Cited by 687
Gabrilove, J. L., Cleeland, C. S., Livingston, R. B., Sarokhan, B., Winer, E., & Einhorn, L. H. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.11.2875 · Cited by 595
Fatigue and the cancer experience: the state of the knowledge.
Winningham, M. L., Nail, L. M., Burke, M., Brophy, L., Cimprich, B., Jones, L. S., Pickard-Holley, S., Rhodes, V. A., Pierre, B. S., & Beck, S. L. (1994) · PubMed · Cited by 522
Erythropoietin Treatment of Anemia Associated with Multiple Myeloma
Ludwig, H., Fritz, E., Kotzmann, H., Höcker, P., Gisslinger, H., & Barnas, U. (1990) · New England Journal of Medicine · doi:10.1056/nejm199006143222402 · Cited by 443
Factors influencing quality of life in cancer patients: anemia and fatigue.
Cella, D. F. (1998) · PubMed · Cited by 386
Cascinu, S., Fedeli, A., Ferro, E. D., Fedeli, S. L., & Catalano, G. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.5.1058 · Cited by 194
Cited by
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177
Weiss, G., & Goodnough, L. T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041809 · Cited by 3,800
Henke, M., Laszig, R., Rübe, C., Schäfer, U., Haase, K.-D., Schilcher, B., Mose, S., Beer, K. T., Burger, U., Dougherty, C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14567-9 · Cited by 1,250
Ludwig, H., Van Belle, S., Barrett-Lee, P., Birgegård, G., Bokemeyer, C., Gascón, P., Kosmidis, P., Krzakowski, M., Nortier, J., Olmi, P., et al. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.06.019 · Cited by 925
Self-citationCella, D., Eton, D. T., Lai, J.-S., Peterman, A. H., & Merkel, D. E. (2002) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(02)00529-8 · Cited by 808
Smith, T. J., Staats, P. S., Deer, T., Stearns, L. J., Rauck, R. L., Boortz-Marx, R. L., Buchser, E., Català, E., Bryce, D. A., Coyne, P. J., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.02.118 · Cited by 736
Bennett, C. L. (2008) · JAMA · doi:10.1001/jama.299.8.914 · Cited by 731
Cancer‐related fatigue: Evolving concepts in evaluation and treatment
Stasi, R., Abriani, L., Beccaglia, P., Terzoli, E., & Amadori, S. (2003) · Cancer · doi:10.1002/cncr.11742 · Cited by 712
Erythropoietin: Physiology and Pharmacology Update
Fisher, J. W. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800101 · Cited by 708
Leyland-Jones, B., Semiglazov, V., Pawlicki, M., Pienkowski, T., Tjulandin, S., Manikhas, G., Makhson, A., Roth, A., Dodwell, D., Baselga, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.150 · Cited by 668
Self-citationBohlius, J., Schmidlin, K., Brillant, C., Schwarzer, G., Trelle, S., Seidenfeld, J., Zwahlen, M., Clarke, M., Weingart, O., Kluge, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60502-x · Cited by 597
Mechanisms of Cancer-Related Fatigue
Ryan, J. L., Carroll, J. K., Ryan, E. P., Mustian, K. M., Fiscella, K., & Morrow, G. R. (2007) · The Oncologist · doi:10.1634/theoncologist.12-s1-22 · Cited by 583
Bohlius, J., Wilson, J., Seidenfeld, J., Piper, M., Schwarzer, G., Sandercock, J., Trelle, S., Weingart, O., Bayliss, S., Djulbegovic, B., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj189 · Cited by 548
Assessment and management of cancer-related fatigue in adults
Ahlberg, K., Ekman, T., Gaston-Johansson, F., & Mock, V. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14186-4 · Cited by 546
Vansteenkiste, J. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.16.1211 · Cited by 477
Breast cancer trial with erythropoietin terminated unexpectedly
Leyland-Jones, B. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01163-x · Cited by 474
Changing patient perceptions of the side effects of cancer chemotherapy
Carelle, N., Piotto, E., Bellanger, A., Germanaud, J., Thuillier, A., & Khayat, D. (2002) · Cancer · doi:10.1002/cncr.10630 · Cited by 454
Crawford, J., Cella, D., Cleeland, C. S., Cremieux, P., Demetri, G. D., Sarokhan, B. J., Slavin, M. B., & Glaspy, J. A. (2002) · Cancer · doi:10.1002/cncr.10763 · Cited by 428
Wright, J. R., Ung, Y. C., Julian, J. A., Pritchard, K. I., Whelan, T. J., Smith, C., Szechtman, B., Roa, W., Mulroy, L., Rudinskas, L., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.1514 · Cited by 428
Rizzo, J. D., Lichtin, A. E., Woolf, S. H., Seidenfeld, J., Bennett, C. L., Cella, D., Djulbegovic, B., Goode, M. J., Jakubowski, A. A., Lee, S. J., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.07.177 · Cited by 417
Auerbach, M., Ballard, H., Trout, J. R., McIlwain, M., Ackerman, A., Bahrain, H., Balan, S., Barker, L., & Rana, J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.119 · Cited by 414
Evidence Report on the Occurrence, Assessment, and Treatment of Fatigue in Cancer Patients
Lawrence, D. P. (2004) · Journal of the National Cancer Institute Monographs · doi:10.1093/jncimonographs/lgh027 · Cited by 396
Erythropoietin or darbepoetin for patients with cancer
Tonia, T., Mettler, A., Robert, N., Schwarzer, G., Seidenfeld, J., Weingart, O., Hyde, C., Engert, A., & Bohlius, J. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003407.pub5 · Cited by 392
Hypoxia and Aggressive Tumor Phenotype: Implications for Therapy and Prognosis
Vaupel, P. (2008) · The Oncologist · doi:10.1634/theoncologist.13-s3-21 · Cited by 383
The Cancer Patient and Quality of Life
Bottomley, A. (2002) · The Oncologist · doi:10.1634/theoncologist.7-2-120 · Cited by 378
Impact of Anemia on Mortality, Cognition, and Function in Community-Dwelling Elderly
Denny, S. D., Kuchibhatla, M. N., & Cohen, H. J. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.08.027 · Cited by 345
Guidelines on the diagnosis and management of multiple myeloma 2005
Smith, A., Wisloff, F., Samson, D., & the UK Myeloma Forum, N. M. S. G. A. B. C. F. S. I. H. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05867.x · Cited by 311
Österborg, A., Brandberg, Y., Molostova, V., Iosava, G., Abdulkadyrov, K., Hedenus, M., & Messinger, D. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.131 · Cited by 310
Rizzo, J. D., Brouwers, M., Hurley, P., Seidenfeld, J., Arcasoy, M. O., Spivak, J. L., Bennett, C. L., Bohlius, J., Evanchuk, D., Goode, M. J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.2201 · Cited by 303
Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines
Aapro, M., Beguin, Y., Bokemeyer, C., Dicato, M., Gascón, P., Glaspy, J., Hofmann, A., Link, H., Littlewood, T., Ludwig, H., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdx758 · Cited by 288
Self-citationDrug therapy for the management of cancer-related fatigue
Minton, O., Richardson, A., Sharpe, M., Hotopf, M., & Stone, P. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006704.pub3 · Cited by 283
A Systematic Review and Meta-Analysis of the Pharmacological Treatment of Cancer-Related Fatigue
Minton, O., Richardson, A., Sharpe, M., Hotopf, M., & Stone, P. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn250 · Cited by 283
Pathogenesis and treatment of anaemia of chronic disease
Weiss, G. (2002) · Blood Reviews · doi:10.1054/blre.2002.0193 · Cited by 277
Henry, D. H., Dahl, N. V., Auerbach, M., Tchekmedyian, S., & Laufman, L. R. (2007) · The Oncologist · doi:10.1634/theoncologist.12-2-231 · Cited by 264
Side-effects of chemotherapy and quality of life in ovarian and breast cancer patients
Kayl, A. E., & Meyers, C. A. (2006) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/01.gco.0000192996.20040.24 · Cited by 254
Pharmacologic Interventions for Fatigue in Cancer and Transplantation: A Meta-Analysis
Tomlinson, D., Robinson, P. D., Oberoi, S., Cataudella, D., Culos-Reed, N., Davis, H., Duong, N., Gibson, F., Götte, M., Hinds, P., et al. (2018) · Current Oncology · doi:10.3747/co.25.3883 · Cited by 68
Theurl, M., Nairz, M., Schroll, A., Sonnweber, T., Asshoff, M., Haschka, D., Seifert, M., Willenbacher, W., Wilflingseder, D., Posch, W., et al. (2014) · Haematologica · doi:10.3324/haematol.2013.099481 · Cited by 42
Evaluation and management of fatigue in oncology: A multidimensional approach
Tazi, E. M., & Errihani, H. (2011) · Indian Journal of Palliative Care · doi:10.4103/0973-1075.84528 · Cited by 10
Metadata
- Authors
- Littlewood, T. J., Bajetta, E., Nortier, J. W. R., Vercammen, E., Rapoport, B., & for the Epoetin Alfa Study Group
- Venue
- Journal of Clinical Oncology
- Published
- 2001-06-01
- Volume
- 19
- Issue
- 11
- Pages
- 2865-2874
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1885881044
- Cited by
- 974
- References
- 17
- FWCI
- 41.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.